BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 7855316)

  • 21. Effect of oxandrolone treatment on the activity of lipoprotein lipase, hepatic lipase and phospholipase A1 of human postheparin plasma.
    Ehnholm C; Huttunen JK; Kinnunen PJ; Miettinen TA; Nikkilä EA
    N Engl J Med; 1975 Jun; 292(25):1314-7. PubMed ID: 1128607
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lipoprotein lipase, hepatic lipase and plasma lipolytic activity. Effects of heparin and a low molecular weight heparin fragment (Fragmin).
    Persson E
    Acta Med Scand Suppl; 1988; 724():1-56. PubMed ID: 2843005
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of weight loss and weight maintenance on the serum lipids, lipoprotein lipase and hepatic triglyceride lipase activities in obese rats.
    Kasim S; Jen KL
    Int J Obes; 1989; 13(3):279-88. PubMed ID: 2767881
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mechanism of oral absorbent AST-120 in lipid abnormalities in experimental uremic rats.
    Yamakado M; Ise M
    Kidney Int Suppl; 1999 Jul; 71():S190-2. PubMed ID: 10412773
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of platelet-activating factor on lipoprotein lipase and blood lipids.
    Mimura K; Yukawa S; Mori Y; Okada K; Mune M; Nishikawa O; Hibino A; Sonobe M; Goto T; Nomoto H
    Lipids; 1991 Dec; 26(12):1102-7. PubMed ID: 1819694
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The lipoprotein lipase system: new understandings.
    Tan MH
    Can Med Assoc J; 1978 Mar; 118(6):675-80. PubMed ID: 207404
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Lipoprotein lipase. Interest in clinical biochemistry (author's transl)].
    Etienne J; Debray J
    Pathol Biol (Paris); 1980 Mar; 28(3):193-6. PubMed ID: 6988774
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Improvement of post-heparin lipolytic activity (PHLA) after haemofiltration, in uraemic patients.
    di Giulio S; Lacour B; Thevenin M; Basile C; Drüeke T; Man NK
    Proc Eur Dial Transplant Assoc; 1980; 17():259-65. PubMed ID: 7243777
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Postheparin lipolytic activity and Intralipid clearance in very low-birth-weight infants.
    Dhanireddy R; Hamosh M; Sivasubramanian KN; Chowdhry P; Scanlon JW; Hamosh P
    J Pediatr; 1981 Apr; 98(4):617-22. PubMed ID: 6782222
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hypertriglyceridemia in patients with chronic renal insufficiency.
    McCosh EJ; Solangi K; Rivers JM; Goodman A
    Am J Clin Nutr; 1975 Sep; 28(9):1036-43. PubMed ID: 1163470
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of slow-release bezafibrate on serum lipids, lipoproteins, apolipoproteins, and postheparin lipolytic activities in patients with type IV and type V hypertriglyceridemia.
    Saku K; Sasaki J; Arakawa K
    Clin Ther; 1989; 11(3):331-40. PubMed ID: 2743372
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Postheparin plasma lipase activities and plasma lipoproteins in newborn infants.
    Rovamo L; Taskinen MR; Kuusi T; Nikkilä EA; Ehnholm C; Raivio KO
    Pediatr Res; 1984 Jul; 18(7):642-7. PubMed ID: 6382135
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lipid clearing in premature infants during continuous heparin infusion: role of circulating lipases.
    Zaidan H; Dhanireddy R; Hamosh M; Bengtsson-Olivecrona G; Hamosh P
    Pediatr Res; 1985 Jan; 19(1):23-5. PubMed ID: 3918289
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lipoprotein particle abnormalities and the impaired lipolysis in renal insufficiency.
    Lee DM; Knight-Gibson C; Samuelsson O; Attman PO; Wang CS; Alaupovic P
    Kidney Int; 2002 Jan; 61(1):209-18. PubMed ID: 11786103
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Postheparin serum lipolytic activity in psoriatic males.
    Pietrzak A; Lecewicz-Toruń B; Borzecki A
    Med Sci Monit; 2000; 6(4):729-34. PubMed ID: 11208400
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The effect of postheparin lipolytic activity (PHLA) and diet on hyperlipoproteinemia in hypothyroidism (author's transl)].
    Haba T
    Nihon Naibunpi Gakkai Zasshi; 1979 Nov; 55(11):1361-71. PubMed ID: 520624
    [No Abstract]   [Full Text] [Related]  

  • 37. Homocitrulline: a new marker for differentiating acute from chronic renal failure.
    Desmons A; Jaisson S; Pietrement C; Rieu P; Wynckel A; Gillery P
    Clin Chem Lab Med; 2016 Jan; 54(1):73-9. PubMed ID: 26124058
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Plasma levels of pancreatic secretory trypsin inhibitor in relation to amylase and lipase in patients with acute and chronic renal failure.
    Hörl WH; Wanner C; Schollmeyer P; Ogawa M
    Nephron; 1988; 49(1):33-8. PubMed ID: 2454413
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lipoprotein metabolism in patients with elevated lipoprotein-lipase activity in adipose tissue.
    Enzi G; Martini S; Baggio G; Baldo G; Digito M; Zanella A
    Int J Obes; 1985; 9 Suppl 1():173-6. PubMed ID: 4066122
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Selective measurement of lipoprotein lipase and hepatic triglyceride lipase in heparinized plasma from horses.
    Watson TD; Burns L; Packard CJ; Shepherd J
    Am J Vet Res; 1992 May; 53(5):771-5. PubMed ID: 1524305
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.